| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Commercial Officer
1 company
Laurence Matthew Skelton is Chief Commercial Officer at VERA. Laurence Matthew Skelton's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $2.0M at current prices.
The VERA filings lean toward selling, a net 1,582 shares.
Laurence Matthew Skelton has 2 Form 4 filings on record in February 2026, all as Chief Commercial Officer at Vera Therapeutics (VERA), 2026.
The 3 reported transactions were 1 open-market sale, 1 stock award and 1 option or other derivative award.
Counted by filing, the open-market trades come to no purchases and 1 sale worth about $66K.
The only open-market sale was 1,582 shares of VERA at an average $41.98 on February 23, 2026, about $66K.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 23, 2026 | VERA Vera Therapeutics, Inc. | Chief Commercial Officer | Sell | 1,582 | $41.98 | $66,418.53 | -2.4% | -18.4% | - |